PARP Inhibitors in Melanoma—An Expanding Therapeutic Option?

por Chan, Wei Yen, Brown, Lauren J., Reid, Lee, Joshua, Anthony M.
Publicado 2021

Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer

por Freelander, Allegra, Brown, Lauren J., Parker, Andrew, Segara, Davendra, Portman, Neil, Lau, Brandon, Lim, Elgene
Publicado 2021

Heart Failure Therapies for the Prevention of HER2-Monoclonal Antibody-Mediated Cardiotoxicity: A Systematic Review and Meta-Analysis of Randomized Trials

por Brown, Lauren J., Meredith, Thomas, Yu, Jie, Patel, Anushka, Neal, Bruce, Arnott, Clare, Lim, Elgene
Publicado 2021

Five‐year survival and clinical correlates among patients with advanced non‐small cell lung cancer, melanoma and renal cell carcinoma treated with immune check‐point inhibitors in...

por Brown, Lauren J, da Silva, Ines Pires, Moujaber, Tania, Gao, Bo, Hui, Rina, Gurney, Howard, Carlino, Matteo, Nagrial, Adnan
Publicado 2022

Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders

por Brown, Lauren J, Weppler, Alison, Bhave, Prachi, Allayous, Clara, Patrinely Jr, J. Randall, Ott, Patrick, Sandhu, Shahneen, Haydon, Andrew, Lebbe, Celeste, Johnson, Douglas B, Long, Georgina V, Menzies, Alexander A, Carlino, Matteo S
Publicado 2021

The EXTrauterine Environment for Neonatal Development Supports Normal Intestinal Maturation and Development

por Baumgarten, Heron D., Wright, Christina M., Rossidis, Avery C., Lawrence, Kendall M., Kim, Aimee G., Mejaddam, Ali Y., McGovern, Patrick E., Orr, Melissa N., Coons, Barbara E., Butt, Zoya, Li, Haiying, Hwang, Grace, Radu, Antoneta, Brown, Lauren J., Rubenstein, Ronald C., Peranteau, William H., Davey, Marcus, Heuckeroth, Robert O., Flake, Alan W.
Publicado 2020